Scholarlink

One form of amyloidosis, β2-microglobulin, is characteristic in renal dialysis patients. Amyloid is deposited in the skeleton and periosteal tissues and is a further manifestation of renal bone disease. About 200 mg of this protein are produced each day on cell surfaces, normally filtered by the glomeruli and catabolised in the tubuli. However, this low-molecular-weight protein does not filter well through dialysis membranes and as a consequence, accumulates in tissues. After ten or more years of dialysis, about 70% of patients are affected. The following manifestations are characteristic:

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Haemodialysis: Associated Amyloidosis

  • 章节

  • 发表日期：

    2026年

查看全文
  • Reiner Bartl,
  • Christoph Bartl

摘要

One form of amyloidosis, β2-microglobulin, is characteristic in renal dialysis patients. Amyloid is deposited in the skeleton and periosteal tissues and is a further manifestation of renal bone disease. About 200 mg of this protein are produced each day on cell surfaces, normally filtered by the glomeruli and catabolised in the tubuli. However, this low-molecular-weight protein does not filter well through dialysis membranes and as a consequence, accumulates in tissues. After ten or more years of dialysis, about 70% of patients are affected. The following manifestations are characteristic: